期刊文献+

鲍氏不动杆菌的药物治疗进展 被引量:6

原文传递
导出
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2010年第17期2716-2718,共3页 Chinese Journal of Nosocomiology
  • 相关文献

参考文献24

  • 1Jawad A, Seifert H, Snelling AM, etal. Survival of Acineto bacter baumannii on dry surfaces"comparison of outbreak and sporadic Isolates[J]. J Clin Microbiol, 1998, 36 (7): 1938- 1941.
  • 2Karageorgopoulos DE, Falagas ME. Current control and treat ment of multidrug resistant Acinetobacter baumannii infections [J]. Lancet Infect Dis,2008,8(12);751-762.
  • 3曹银光,吴红敏,刁艳蕾,张瑾,程鹏,公茂庆.鲍曼不动杆菌耐药性及抗菌药物的选择[J].中国病原生物学杂志,2009,4(3):224-225. 被引量:21
  • 4Poirel I J, Nordmann P. Carbapenem resistance in Acinetobacter baurnannii:mechanisms and epidemiology[J]. Clin Microbiol Infect, 2006,12(9) : 826-836.
  • 5周铁丽,林小玲,冯红军,李超,刘庆中,王赛芳,王邦松.鲍氏不动杆菌对亚胺培南耐药机制研究[J].中华医院感染学杂志,2007,17(4):375-378. 被引量:16
  • 6史俊艳,张小江,徐英春,俞云松,杨青,汪复,朱德妹,倪语星,孙景勇,孙自镛,简翠,胡云健,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,薛建昌,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍.2007年中国CHINET鲍曼不动杆菌耐药性监测[J].中国感染与化疗杂志,2009,9(3):196-200. 被引量:152
  • 7Souli M, Galani I, Giamarellou H. Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe[J]. Eur Surveill,2008,13(47) : 1-11.
  • 8Choi JY, Kim CO, Park YS, et al. Comparison of efficacy of cefoperazone/sulbactam and imipenem/cilastatin for treatment of Acinetobacter bacteremia[J]. Yonsei Med J, 2006,47 (1) : 63 -69.
  • 9Betrosian AP, Frantzeskaki F, Xanthaki A, et al. Efficacy and safety of high-dose ampicillin/snlbactam vs colistin as monotherapy for the treatment of multidrug resistant Acine tobacter baumannii ventilator associated pneumonia[J].J Infect, 2008,56(6) : 432-436.
  • 10Corbella X, Ariza J, Ardanuy C, et al. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii [ J ]. J Antimicrob Chemother, 1998,42 (6) : 793 -802.

二级参考文献38

共引文献183

同被引文献41

  • 1谈华,邵海枫,王锦娜,王卫萍,李珍大.舒巴坦单剂及舒巴坦与第三代头孢菌素联合对鲍曼不动杆菌的体外抗菌作用比较[J].中国抗生素杂志,2006,31(8):488-491. 被引量:39
  • 2颜青,肖永红,何绥平.必须重视β内酰胺类抗生素与其酶抑制剂复方制剂的科学开发[J].中国临床药学杂志,2007,16(4):259-261. 被引量:9
  • 3倪语星,尚红,吴爱武,等.临床微生物学与检验[M].4版.北京:人民卫生出版社,2010:532.
  • 4薛原.抗菌药物规范使用迫在眉睫-访卫生部医院管理研究所药事管理研究部主任吴永佩[N].健康报,2011-08-23(5).
  • 5Clinical, Laboratory Standards Institute (CLSI). Performance Standards for Antimierobial Susceptibility Testing; Eigh- teenth Informational Supplement[S]. Clinical and Laboratory Standards Institute, 2010,100-18.
  • 6Nicola C, Gordon, David W, et al. Multidrug-resistant Acine- tobacter Baumannii:Mechanisms of Virulence and Resistance [J]. International Journal of Antimicrobial Agents, 2010, 35 : 219-226.
  • 7Drosos E, Theodore K. Tigecyeline for the Treatment of Mul- tidrug Resisdant (Including Carbapeneu Resistant) Acineto- baeter Infections: A Review of Scientific Evidence[J]. J Amti- mierob Chemother, 2008,62 : 45-55.
  • 8Tasbakan M S,Pullukeu H,Ekren P K,et al. Colistin Use in Ventilator-Associtated Pneumonia Due to Panresistant Pseud- omonas AeruginosaAnd Aeinetobacter Baumannii[J]. Mik- robiyol Bul,2009,43161-70.
  • 9Jama[ W, Sa/ama M, Dehrab N, et al. Rol.e of Tigeeycllne in the Control of a Carbapenem Resistant Aeinetobaeter Bau- mannii Outbreak in an Intensive Care Unit[J]. J Hosp Infect, 2009,72(3) s 234-242.
  • 10项勤,朱国飞,李婷婷.鲍曼不动杆菌的分布特点及耐药性分析[J].中国预防医学杂志,2008,9(3):226-227. 被引量:26

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部